DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) – Inozyme Pharma, Inc. Transaction History
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) portfolio value:
$5.60M
portfolio value
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) quarter portfolio value change:
-43.82%
quarter
Inozyme Pharma, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -22.47% | -605.93K shares | -7.26M | $2.68 | 2.09M |
| Q2 2022 | share | Increase | +14.99% | 351.58K shares | 3.27M | $4.77 | 2.69M |
| Q1 2022 | share | 0.00% | 0 shares | -6.40M | $4.09 | 2.34M | |
| Q4 2021 | share | 0.00% | 0 shares | -11.18M | $6.95 | 2.34M | |
| Q3 2021 | share | Increase | +7.61% | 165.80K shares | -9.95M | $11.59 | 2.34M |
| Q2 2021 | share | Increase | +10.95% | 214.98K shares | -1.75M | $17.04 | 2.17M |
| Q1 2021 | share | Increase | +70.74% | 813.70K shares | 15.14M | $19.8 | 1.96M |
| Q4 2020 | share | 0.00% | 0 shares | -6.49M | $20.64 | 1.15M | |
| Q3 2020 | share | Increase | 0.00% | 1.15M shares | 30.24M | $26.29 | 1.15M |